LRP1 and neoplasm: Interestingly, MMP-2 and MMP-9 can bind to low-density lipoprotein receptor-related protein 1 (LRP1), activate ERK, inhibit the JNK pathway, facilitate tight adhesion of tumor cells to the stroma, and induce tumor cell invasion into blood vessels and lymphatic vessels (41).